Finance
Robert W. Baird slashes price target on Pieris Pharmaceuticals Inc [PIRS] – find out why.
Pieris Pharmaceuticals Inc [NASDAQ: PIRS] traded at a high on Monday, posting a 24.26 gain after which it closed the day’ session at $0.21. The company report on August 17, 2023 at 8:00 AM that Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals’ Initiation of
